Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Comparison of Laboratory Data of Patients with Tafro Syndrome and Idiopathic Multicentric Castleman Disease: A Japanese Retrospective Study

Shino Fujimoto, MD, Hiroshi Kawabata, MD PhD, Nozomu Kurose, MD PhD, Kazue Takai, MD PhD, Masaru Kojima, MD PhD, Norifumi Tsukamoto, MD PhD, Tomohiro Kinoshita, MD PhD, Shigeo Nakamura, MD PhD, Sadao Aoki, MD PhD, Yasufumi Masaki, MD PhD

Blood (2016) 128 (22): 4893.

https://doi.org/10.1182/blood.V128.22.4893.4893

Published: 2016

Journal Articles

Early Responses At 3 Months and 12 Months After Starting Imatinib As Predictive Factors For The Achievement Of Deep MR In Japanese CML Patients

Masayoshi Masuko, MD, PhD, Tatsuo Furukawa, MD, PhD, Tadashi Koike, MD, Kazue Takai, MD, Koichi Nagai, MD, Kenji Kishi, MD, PhD, Yoshinobu Seki, MD, Hoyu Takahashi, MD, PhD, Sadao Aoki, MD, PhD, Takashi Kozakai, MD, Yasuhiko Shibasaki, MD, Takashi Ushiki, MD, Ken Toba, MD, PhD, Miwako Narita, MD, PhD, Masuhiro Takahashi, MD, PhD, Hirohito Sone, MD, PhD, Akira Shibata, MD

Blood (2013) 122 (21): 2744.

https://doi.org/10.1182/blood.V122.21.2744.2744

Published: 2013

Journal Articles

Correlation Between Imatinib Trough Concentration and Long-Term Tolerability in CML Patients

Masayoshi Masuko, MD, PhD, Tatsuo Furukawa, MD, PhD, Toyoyuki Tanaka, MD, Syukuko Miyakoshi, MD, Takashi Kozakai, MD, Kyoko Fuse, MD, Yasuhiko Shibasaki, MD, Kazue Takai, MD, Yoshinobu Seki, MD, Masashi Kobayashi, MD, Koichi Nagai, MD, Hoyu Takahashi, MD, Kenji Kishi, MD, PhD, Miwako Narita, MD, PhD, Masuhiro Takahashi, Tadashi Koike, MD, Akira Shibata, MD

Blood (2012) 120 (21): 3751.

https://doi.org/10.1182/blood.V120.21.3751.3751

Published: 2012

Journal Articles

Micafungin Is Extremely Effective Against Fungal Infections Complicating Hematological Malignancies: Report of a Multicenter Study by N-FISH (Niigata Fungal Infection Study Group in Hematology).

Sadao Aoki, MD, PhD, Jun Takizawa, MD, PhD, Yoshinobu Seki, MD, Kazue Takai, MD, Koji Nikkuni, MD, PhD, Souichi Maruyama, MD, PhD, Nobuhiko Nomoto, MD, PhD, Nobuhiro Tsukada, MD, PhD, Yoshifusa Aizawa, MD

Blood (2005) 106 (11): 5350.

https://doi.org/10.1182/blood.V106.11.5350.5350

Published: 2005

Journal Articles

A Phase II Clinical Study of Rituximab and High-Dose Biweekly THP-COP (Pirarubicin, Cyclophosphamide, Vincristine and Predonisolone) with G-CSF for Non-Hodgkin Lymphoma: Results of a Multicentric Study of NMLSG (Niigata Malignant Lymphoma Study Group).

Jun Takizawa, MD, PhD, Sadao Aoki, MD, PhD, Kazue Takai, MD, Tohri Kurasaki, MD, Keiichiro Honma, MD, Masutaka Higashimura, MD, Kouichi Nagai, MD, Akihito Momoi, MD, PhD, Koji Nikkuni, MD, PhD, Yoshufusa Aizawa, MD

Blood (2005) 106 (11): 4734.

https://doi.org/10.1182/blood.V106.11.4734.4734

Published: 2005

NARROW

Comparison of Laboratory Data of Patients with Tafro Syndrome and Idiopathic Multicentric Castleman Disease: A Japanese Retrospective Study

Early Responses At 3 Months and 12 Months After Starting Imatinib As Predictive Factors For The Achievement Of Deep MR In Japanese CML Patients

Correlation Between Imatinib Trough Concentration and Long-Term Tolerability in CML Patients

Micafungin Is Extremely Effective Against Fungal Infections Complicating Hematological Malignancies: Report of a Multicenter Study by N-FISH (Niigata Fungal Infection Study Group in Hematology).

A Phase II Clinical Study of Rituximab and High-Dose Biweekly THP-COP (Pirarubicin, Cyclophosphamide, Vincristine and Predonisolone) with G-CSF for Non-Hodgkin Lymphoma: Results of a Multicentric Study of NMLSG (Niigata Malignant Lymphoma Study Group).

Email alerts

ASH Publications

American Society of Hematology

Comparison of Laboratory Data of Patients with Tafro Syndrome and Idiopathic Multicentric Castleman Disease: A Japanese Retrospective Study

Early Responses At 3 Months and 12 Months After Starting Imatinib As Predictive Factors For The Achievement Of Deep MR In Japanese CML Patients

Correlation Between Imatinib Trough Concentration and Long-Term Tolerability in CML Patients

Micafungin Is Extremely Effective Against Fungal Infections Complicating Hematological Malignancies: Report of a Multicenter Study by N-FISH (Niigata Fungal Infection Study Group in Hematology).

A Phase II Clinical Study of Rituximab and High-Dose Biweekly THP-COP (Pirarubicin, Cyclophosphamide, Vincristine and Predonisolone) with G-CSF for Non-Hodgkin Lymphoma: Results of a Multicentric Study of NMLSG (Niigata Malignant Lymphoma Study Group).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only